Barclays PLC Oncocyte Corp Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.86 - $1.53 $8,364 - $14,880
-9,726 Reduced 99.58%
41 $0
Q1 2022

May 16, 2022
SELL
$1.15 - $2.25 $72,759 - $142,355
-63,269 Reduced 86.63%
9,767 $14,000
Q4 2021

Feb 14, 2022
BUY
$2.04 - $3.59 $98,825 - $173,913
48,444 Added 196.99%
73,036 $158,000
Q3 2021

Nov 09, 2021
BUY
$3.53 - $5.89 $50,888 - $84,910
14,416 Added 141.67%
24,592 $87,000
Q2 2021

Aug 13, 2021
SELL
$3.77 - $6.0 $375,088 - $596,958
-99,493 Reduced 90.72%
10,176 $58,000
Q1 2021

May 13, 2021
BUY
$2.39 - $6.5 $93,886 - $255,339
39,283 Added 55.81%
109,669 $569,000
Q4 2020

Feb 11, 2021
SELL
$1.38 - $2.63 $11,536 - $21,986
-8,360 Reduced 10.62%
70,386 $168,000
Q3 2020

Nov 12, 2020
SELL
$1.2 - $1.89 $54,114 - $85,229
-45,095 Reduced 36.41%
78,746 $110,000
Q2 2020

Aug 12, 2020
SELL
$1.91 - $3.45 $102,412 - $184,985
-53,619 Reduced 30.21%
123,841 $237,000
Q1 2020

May 13, 2020
BUY
$1.76 - $3.02 $11,839 - $20,315
6,727 Added 3.94%
177,460 $434,000
Q4 2019

Feb 10, 2020
BUY
$1.51 - $2.27 $241,803 - $363,506
160,135 Added 1510.99%
170,733 $384,000
Q3 2019

Nov 14, 2019
SELL
$1.59 - $2.51 $5,180 - $8,177
-3,258 Reduced 23.51%
10,598 $22,000
Q2 2019

Aug 14, 2019
SELL
$2.49 - $5.45 $10,754 - $23,538
-4,319 Reduced 23.76%
13,856 $35,000
Q1 2019

May 15, 2019
BUY
$1.47 - $5.91 $26,712 - $107,396
18,172 Added 605733.31%
18,175 $72,000
Q2 2018

Aug 14, 2018
SELL
$2.0 - $3.3 $1,602 - $2,643
-801 Reduced 99.63%
3 $0
Q1 2018

May 15, 2018
BUY
$1.25 - $4.6 $240 - $883
192 Added 31.37%
804 $2,000
Q4 2017

Feb 14, 2018
BUY
$3.9 - $7.4 $2,020 - $3,833
518 Added 551.06%
612 $3,000
Q3 2017

Nov 14, 2017
BUY
$4.55 - $7.55 $427 - $709
94
94 $1,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $266M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email